Abstract
Cancer of the prostate constitutes a significant health problem. In Denmark prostatic cancer is the third leading cause of death from cancer in men, following lung and colorectal cancer [14,28]. The incidence and mortality have increased significantly over the last four decades [7]. In part, this trend may be explained by better diagnostic capabilities and improved registration, but data from other Nordic countries and international reports [41] support a true increase in incidence of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackermann R, Frohmüller HGW (1983) Complications and morbidity following radical prostatectomy. World J Urol 1:62–67
Adami H-O (1988) Strategies for control of prostatic cancer mortality with some methodologic comments. Scand J Urol Nephrol Suppl 110:15–22
Adami H-O, Norlén BJ, Malker B, Meirik O (1986) Long-term survival in prostatic carcinoma, with special reference to age as a prognostic factor. A nation-wide study. Scand J Urol Nephrol 20:107–112
Annual Cancer Statistics Review including Cancer Trends: 1950-1985 (1988). National Cancer Institute, Bethesda
Bagshaw MA, Ray GR, Cox RS (1987) Selecting initial therapy for prostate cancer. Radiation therapy perspective. Cancer 60:521–525
Breslow N, Chan CW, Dhom G, Drury RAB, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H (1977) Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 20:680–688
Carstensen B, Storm HH (1987) Overlevelseskurver fra Cancerregisteret 1948-82. Danish Cancer Registry
Chodak GW (1988) Early detection of prostate cancer. Presented at the International Symposium on Endocrine Therapy, Monaco
Chodak GW, Keller P, Schoenberg H (1989) Assessment of screening for prostate cancer using the digital rectal examination. J Urol 141:1136–1138
Chodak GW, Keller P, Schoenberg H (1988) Routine screening for prostate cancer using the digital rectal examination. In: Schroeder FH et al. (eds) EORTC Genitourinary Group, monograph 5: progress and controversies in oncological urology II. Liss, New York, pp 87–95
Cochrane AL, Holland WW (1971) Validation of screening procedures. Br Med Bull 27:3–8
Cole P, Morrison AS (1978) Basic issues in cancer screening. In: Miller EB (ed) Screening in cancer. International Union Against Cancer, Geneva
Commission on Chronic Illness in the United States. Harvard University Press, Cambridge
Danish Cancer Society (1985) Danish Cancer Registry: cancer incidence in Denmark 1985
Franks LM (1954) Latent carcinoma of the prostate. J Pathol Bacteriol 68:603–616
Gilbertsen VA (1971) Cancer of the prostate gland. Results of early diagnosis and therapy undertaken for cure of the disease. JAMA 215:81–84
Henderson M (1976) Validity of screening. Cancer 37:573–581
Jacobi GH (1987) Early detection of prostatic carcinoma: the German experience. Presented at: Progress and Controversies in Oncological Urology II, Amsterdam
Johansson J-E, Adami H-O, Andersson S-O, Bergström R, Krusemo UB, Kraaz W (1989) Natural history of localised prostatic cancer: A population-based study in 223 untreated patients. Lancet i:799–803
Lee F, Littrup PJ, Torp-Pedersen ST, Mettlin C, McHugh TA, Gray JM, Kumasaka GH, McLeary RD (1988) Prostate cancer: comparison of transrectal US and digital rectal examination for screening. Radiology 168:389–394
Life table for the years 1985-1986. (1988) Statistical Year Book
Love RR (1985) Principles of cancer screening. In: Stoll BA (ed) New horizons in oncology: screening and monitoring of cancer, vol 4. Wiley, New York
Love RR, Camilli AE (1981) The value of screening. Cancer 48:489–494
McClennan BL (1988) Transrectal US of the prostate: is the technology leading the science? Radiology 168:571–575
McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha FS, Stamey TA (1986) Patterns of progression in prostate cancer. Lancet i:60–63
Mueller EJ, Crain TW, Thompson IM, Rodriguez FR (1988) An evaluation of serial digital rectal examination in screening for prostate cancer. J Urol 140:1445–1447
Murphy GP, Natarajan N, Pontes JE, Schmitz RL, Smart CR, Schmidt JD, Mettlin C (1982) The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol 127:928–934
National Board of Health (1985) Causes of death in Denmark
Ragde H, Aldape HC, Blasko JC, Bagley CM (1988) Prostate cancer screening with high resolution transrectal ultrasound. Presented at the 3rd International Symposium on Transrectal Ultrasound of the Prostate, Kiel
Resnick M (1988) Background for screening — epidemiology and cost effectiveness. In: Schroeder FH et al. (eds) EORTC Genitourinary Group monograph 5: progress and controversies in oncological urology II. Liss, New York, pp 111–120
Sheldon CA, Williams RD, Fraley EE (1980) Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 124:626–631
Sogani PC, Fair WR (1987) Treatment of advanced prostatic cancer. Urol Clin North Am 14:353–371
Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909–916
Starklint H (1950) Unders0gelser over latent og manifest prostatacancer. Munksgård, Copenhagen
Tannock IF (1985) Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate? J Clin Oncol 3:1013–1021
Thompson IM, Ernst JJ, Gangai MP, Spence CR (1984) Adenocarcinoma of the prostate: results of routine urological screening. J Urol 132:690–692
Thompson IM, Rounder JB, Teague JL, Peek M, Spence CR (1987) Impact of routine screening for adenocarcinoma of the prostate on stage distribution. J Urol 137:424–426
Varenhorst E, Enlund A-L, Herder A, Malmquist E, Berglund K, Löfman O, Carlsson P, Pedersen K (1989) Prostatacancerscreening med rektalpalpation kan organiseres til rimlig kostnad. Läkartidningen 86:3475–3477
Veterans Administration Cooperative Urological Research Group (1967) Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obstet 124:1011–1017
Walsh PC, Lepor H (1987) The role of radical prostatectomy in the management of prostatic cancer. Cancer 60:526–537
Waterhouse J, Muir C, Shanmugaratnam K, Powell J (1982) Cancer incidence in five continents, vol 4. IARC, Lyon (IARC scientific publication no 42)
Watson RA, Tang DB (1980) The predictive value of prostatic acid phosphatase as a screening test for prostate cancer. N Engl J Med 303:497–499
Zaridze DG, Boyle P (1987) Cancer of the prostate: epidemiology and aetiology. Br J Urol 59:493–502
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Iversen, P., Torp-Pedersen, S.T. (1993). Screening for Carcinoma of the Prostate: Epidemiological and Methodological Aspects. In: Ackermann, R., Diehl, V. (eds) Malignancies of the Genitourinary Tract. Recent Results in Cancer Research, vol 126. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84583-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-84583-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84585-7
Online ISBN: 978-3-642-84583-3
eBook Packages: Springer Book Archive